TY  - GEN
AU  - Tazdait,M
AU  - Mezquita,L
AU  - Lahmar,J
AU  - Ferrara,R
AU  - Bidault,F
AU  - Ammari,S
AU  - Balleyguier,C
AU  - Planchard,D
AU  - Gazzah,A
AU  - Soria,J C
AU  - Marabelle,A
AU  - Besse,B
AU  - Caramella,C
TI  - Patterns of responses in metastatic NSCLC during PD-1 or PDL-1 inhibitor therapy: Comparison of RECIST 1.1, irRECIST and iRECIST criteria
SN  - 1879-0852
PY  - 2018///0813
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - B7-H1 Antigen
KW  - antagonists & inhibitors
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Disease Progression
KW  - Female
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Metastasis
KW  - Programmed Cell Death 1 Receptor
KW  - Response Evaluation Criteria in Solid Tumors
KW  - Retrospective Studies
N1  - Publication Type: Comparative Study; Journal Article
UR  - https://doi.org/10.1016/j.ejca.2017.10.017
ER  -